AFAXYS FDA Approval ANDA 215132

ANDA 215132

AFAXYS

FDA Drug Application

Application #215132

Application Sponsors

ANDA 215132AFAXYS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION1%0LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-06-09STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

AFAXYS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215132
            [companyName] => AFAXYS
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIDOCAINE HYDROCHLORIDE","activeIngredients":"LIDOCAINE HYDROCHLORIDE","strength":"1%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/09\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-06-09
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.